SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-025524
Filing Date
2024-02-20
Accepted
2024-02-20 16:14:41
Documents
15
Period of Report
2024-02-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246758d1_8k.htm   iXBRL 8-K 31940
  Complete submission text file 0001104659-24-025524.txt   264875

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrk-20240215.xsd EX-101.SCH 4077
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20240215_def.xml EX-101.DEF 27973
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20240215_lab.xml EX-101.LAB 38099
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20240215_pre.xml EX-101.PRE 26585
16 EXTRACTED XBRL INSTANCE DOCUMENT tm246758d1_8k_htm.xml XML 8224
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 24653462
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)